Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Author response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Portaccio E, Amato MP.

Neurology. 2018 Oct 30;91(18):851. doi: 10.1212/WNL.0000000000006430. No abstract available.

PMID:
30373926
2.

The dilemma of benign multiple sclerosis: Can we predict the risk of losing the "benign status"? A 12-year follow-up study.

Razzolini L, Portaccio E, Stromillo ML, Goretti B, Niccolai C, Pastò L, Righini I, Prestipino E, Battaglini M, Giorgio A, De Stefano N, Amato MP.

Mult Scler Relat Disord. 2018 Nov;26:71-73. doi: 10.1016/j.msard.2018.08.011. Epub 2018 Aug 18.

PMID:
30237106
3.

Multiple sclerosis and cognition: synaptic failure and network dysfunction.

Di Filippo M, Portaccio E, Mancini A, Calabresi P.

Nat Rev Neurosci. 2018 Oct;19(10):599-609. doi: 10.1038/s41583-018-0053-9. Review.

PMID:
30158590
4.

A decline in cognitive function should lead to a change in disease-modifying therapy - No.

Portaccio E.

Mult Scler. 2018 Nov;24(13):1683-1684. doi: 10.1177/1352458518783357. Epub 2018 Jul 16. No abstract available.

PMID:
30010469
5.

Score on Coma Recovery Scale-Revised at admission predicts outcome at discharge in intensive rehabilitation after severe brain injury.

Portaccio E, Morrocchesi A, Romoli AM, Hakiki B, Taglioli MP, Lippi E, Di Renzone M, Grippo A, Macchi C.

Brain Inj. 2018;32(6):730-734. doi: 10.1080/02699052.2018.1440420. Epub 2018 Feb 26.

PMID:
29482376
6.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Portaccio E, Annovazzi P, Ghezzi A, Zaffaroni M, Moiola L, Martinelli V, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Patti F, Solaro C, Bellantonio P, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e823-e831. doi: 10.1212/WNL.0000000000005067. Epub 2018 Feb 7.

PMID:
29438046
7.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.

Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Solaro C, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.

PMID:
29438041
8.

Improvement on the Coma Recovery Scale-Revised During the First Four Weeks of Hospital Stay Predicts Outcome at Discharge in Intensive Rehabilitation After Severe Brain Injury.

Portaccio E, Morrocchesi A, Romoli AM, Hakiki B, Taglioli MP, Lippi E, Di Renzone M, Grippo A, Macchi C; Intensive Rehabilitation Unit Study Group of the IRCCS Don Gnocchi Foundation, Italy.

Arch Phys Med Rehabil. 2018 May;99(5):914-919. doi: 10.1016/j.apmr.2018.01.015. Epub 2018 Feb 8.

PMID:
29428346
9.

Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical Disability.

Giorgio A, Zhang J, Stromillo ML, Rossi F, Battaglini M, Nichelli L, Mortilla M, Portaccio E, Hakiki B, Amato MP, De Stefano N.

Front Neurol. 2017 Nov 14;8:608. doi: 10.3389/fneur.2017.00608. eCollection 2017.

10.

Maturational Trajectory of Processing Speed Performance in Pediatric Multiple Sclerosis.

Akbar N, Signori A, Amato MP, Sormani MP, Portaccio E, Niccolai C, Goretti B, Till C, Banwell B.

Dev Neuropsychol. 2017;42(5):299-308. doi: 10.1080/87565641.2017.1351974. Epub 2017 Sep 5.

PMID:
28872902
11.

Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study.

Ruano L, Branco M, Portaccio E, Goretti B, Niccolai C, Patti F, Chisari C, Gallo P, Grossi P, Ghezzi A, Roscio M, Mattioli F, Stampatori C, Simone M, Viterbo RG, Amato MP.

Mult Scler. 2018 Aug;24(9):1234-1242. doi: 10.1177/1352458517717341. Epub 2017 Jun 27.

PMID:
28654357
12.

Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.

Ruano L, Portaccio E, Goretti B, Niccolai C, Severo M, Patti F, Cilia S, Gallo P, Grossi P, Ghezzi A, Roscio M, Mattioli F, Stampatori C, Trojano M, Viterbo RG, Amato MP.

Mult Scler. 2017 Aug;23(9):1258-1267. doi: 10.1177/1352458516674367. Epub 2016 Oct 13.

PMID:
27738090
13.

Differential diagnosis, discerning depression from cognition.

Portaccio E.

Acta Neurol Scand. 2016 Sep;134 Suppl 200:14-8. doi: 10.1111/ane.12652. Review.

PMID:
27580901
14.

History of multiple sclerosis in 2 successive pregnancies: A French and Italian cohort.

Benoit A, Durand-Dubief F, Amato MP, Portaccio E, Casey R, Roggerone S, Androdias G, Gignoux L, Ionescu I, Marrosu MG, Cocco E, Ghezzi A, Annovazzi P, Trojano M, Simone M, Marignier R, Confavreux C, Vukusic S.

Neurology. 2016 Sep 27;87(13):1360-7. doi: 10.1212/WNL.0000000000003036. Epub 2016 Jul 27.

PMID:
27466470
15.

Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study.

Paolicelli D, Cocco E, Di Lecce V, Direnzo V, Moiola L, Lanzillo R, Perini P, Malucchi S, Borriello G, Portaccio E, Panetta V, Fenu G, Sangalli F, Cacciaguerra L, Trojano M; TRACER Group.

Expert Opin Drug Deliv. 2016 Jun;13(6):799-805. doi: 10.1517/17425247.2016.1158161. Epub 2016 Mar 12.

PMID:
26922837
16.

The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis.

Pastò L, Portaccio E, Goretti B, Ghezzi A, Lori S, Hakiki B, Giannini M, Righini I, Razzolini L, Niccolai C, Moiola L, Falautano M, Simone M, Viterbo RG, Patti F, Cilia S, Pozzilli C, Bianchi V, Roscio M, Martinelli V, Comi G, Trojano M, Amato MP; MS Study Group of the Italian Neurological Society.

Mult Scler. 2016 Nov;22(13):1741-1749. Epub 2016 Feb 11.

PMID:
26869527
17.

A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.

Niccolai C, Portaccio E, Goretti B, Hakiki B, Giannini M, Pastò L, Righini I, Falautano M, Minacapelli E, Martinelli V, Incerti C, Nocentini U, Fenu G, Cocco E, Marrosu MG, Garofalo E, Ambra FI, Maddestra M, Consalvo M, Viterbo RG, Trojano M, Losignore NA, Zimatore GB, Pietrolongo E, Lugaresi A, Pippolo L, Roscio M, Ghezzi A, Castellano D, Stecchi S, Amato MP.

BMC Neurol. 2015 Oct 15;15:204. doi: 10.1186/s12883-015-0460-8.

18.

Regional hippocampal involvement and cognitive impairment in pediatric multiple sclerosis.

Rocca MA, Morelli ME, Amato MP, Moiola L, Ghezzi A, Veggiotti P, Capra R, Pagani E, Portaccio E, Fiorino A, Pippolo L, Pera MC, Comi G, Falini A, Filippi M.

Mult Scler. 2016 Apr;22(5):628-40. doi: 10.1177/1352458515598569. Epub 2015 Aug 18.

PMID:
26286701
19.

Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.

De Stefano N, Stromillo ML, Giorgio A, Bartolozzi ML, Battaglini M, Baldini M, Portaccio E, Amato MP, Sormani MP.

J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):93-9. doi: 10.1136/jnnp-2014-309903. Epub 2015 Apr 22.

20.

Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.

Amato MP, Portaccio E.

CNS Drugs. 2015 Mar;29(3):207-20. doi: 10.1007/s40263-015-0238-y. Review.

PMID:
25773609
21.

Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures.

Giorgio A, Stromillo ML, De Leucio A, Rossi F, Brandes I, Hakiki B, Portaccio E, Amato MP, De Stefano N.

J Neurosci. 2015 Jan 14;35(2):550-8. doi: 10.1523/JNEUROSCI.2557-14.2015.

22.

Neuropsychological features in childhood and juvenile multiple sclerosis: five-year follow-up.

Amato MP, Goretti B, Ghezzi A, Hakiki B, Niccolai C, Lori S, Moiola L, Falautano M, Viterbo RG, Patti F, Cilia S, Pozzilli C, Bianchi V, Roscio M, Martinelli V, Comi G, Portaccio E, Trojano M; MS Study Group of the Italian Neurological Society.

Neurology. 2014 Oct 14;83(16):1432-8. doi: 10.1212/WNL.0000000000000885. Epub 2014 Sep 12.

PMID:
25217060
23.

The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population.

Goretti B, Niccolai C, Hakiki B, Sturchio A, Falautano M, Minacapelli E, Martinelli V, Incerti C, Nocentini U, Murgia M, Fenu G, Cocco E, Marrosu MG, Garofalo E, Ambra FI, Maddestra M, Consalvo M, Viterbo RG, Trojano M, Losignore NA, Zimatore GB, Pietrolongo E, Lugaresi A, Langdon D, Portaccio E, Amato MP.

BMC Neurol. 2014 Sep 10;14:171. doi: 10.1186/s12883-014-0171-6.

24.

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.

Pecori C, Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Sturchio A, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, Mancardi GL, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

BMC Neurol. 2014 May 26;14:114. doi: 10.1186/1471-2377-14-114.

25.

Emotional and neutral verbal memory impairment in Multiple Sclerosis.

Iaffaldano P, Viterbo RG, Goretti B, Portaccio E, Amato MP, Trojano M.

J Neurol Sci. 2014 Jun 15;341(1-2):28-31. doi: 10.1016/j.jns.2014.03.038. Epub 2014 Mar 26.

PMID:
24713509
26.

Posterior brain damage and cognitive impairment in pediatric multiple sclerosis.

Rocca MA, Absinta M, Amato MP, Moiola L, Ghezzi A, Veggiotti P, Capra R, Portaccio E, Fiorino A, Pippolo L, Pera MC, Horsfield MA, Falini A, Comi G, Filippi M.

Neurology. 2014 Apr 15;82(15):1314-21. doi: 10.1212/WNL.0000000000000309. Epub 2014 Mar 19.

27.

Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.

Portaccio E, Ghezzi A, Hakiki B, Sturchio A, Martinelli V, Moiola L, Patti F, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, De Luca G, Paolicelli D, Marrosu MG, Comi G, Trojano M, Amato MP; MS Study Group of the Italian Neurological Society.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):845-50. doi: 10.1136/jnnp-2013-306054. Epub 2014 Jan 8.

PMID:
24403285
28.

The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population.

Goretti B, Patti F, Cilia S, Mattioli F, Stampatori C, Scarpazza C, Amato MP, Portaccio E.

Neurol Sci. 2014 Jan;35(1):79-82. doi: 10.1007/s10072-013-1558-7. Epub 2013 Oct 8.

PMID:
24101117
29.

Anxiety state affects information processing speed in patients with multiple sclerosis.

Goretti B, Viterbo RG, Portaccio E, Niccolai C, Hakiki B, Piscolla E, Iaffaldano P, Trojano M, Amato MP.

Neurol Sci. 2014 Apr;35(4):559-63. doi: 10.1007/s10072-013-1544-0. Epub 2013 Sep 27.

PMID:
24072658
30.

Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial.

Amato MP, Goretti B, Viterbo RG, Portaccio E, Niccolai C, Hakiki B, Iaffaldano P, Trojano M.

Mult Scler. 2014 Jan;20(1):91-8. doi: 10.1177/1352458513501571. Epub 2013 Aug 19.

PMID:
23959713
31.

Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.

Ghezzi A, Annovazzi P, Portaccio E, Cesari E, Amato MP.

Expert Rev Clin Immunol. 2013 Jul;9(7):683-91; quiz 692. doi: 10.1586/1744666X.2013.811046. Review.

PMID:
23899239
32.

Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis.

Lolli F, Martini H, Citro A, Franceschini D, Portaccio E, Amato MP, Mechelli R, Annibali V, Sidney J, Sette A, Salvetti M, Barnaba V.

J Neuroinflammation. 2013 Jul 27;10:94. doi: 10.1186/1742-2094-10-94.

33.

Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis.

Giorgio A, Stromillo ML, Bartolozzi ML, Rossi F, Battaglini M, De Leucio A, Guidi L, Maritato P, Portaccio E, Sormani MP, Amato MP, De Stefano N.

Mult Scler. 2014 Feb;20(2):214-9. doi: 10.1177/1352458513494490. Epub 2013 Jul 22.

PMID:
23877971
34.

Causes of diplopia in the emergency department: diagnostic accuracy of clinical assessment and of head computed tomography.

Nazerian P, Vanni S, Tarocchi C, Portaccio E, Vannucci N, Para O, Giannazzo G, Gigli C, Grifoni S.

Eur J Emerg Med. 2014 Apr;21(2):118-24. doi: 10.1097/MEJ.0b013e3283636120.

PMID:
23788113
35.

Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire).

Solaro C, Rezzani C, Trabucco E, Amato MP, Zipoli V, Portaccio E, Giannini M, Patti F, D'Amico E, Frau J, Lorefice L, Bonavita S, Della Corte M, Grasso MG, Finamore L, Ghezzi A, Annovazzi P, Rottoli M, Gasperini C, Restivo D, Maimone D, Rossi P, Stromillo ML, Bergamaschi R.

J Neurol Sci. 2013 Aug 15;331(1-2):94-7. doi: 10.1016/j.jns.2013.05.020. Epub 2013 Jun 6.

PMID:
23747002
36.

Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient.

Piscolla E, Hakiki B, Pastò L, Razzolini L, Portaccio E, Amato MP.

J Neurol. 2013 Jun;260(6):1675-7. doi: 10.1007/s00415-013-6933-z. Epub 2013 May 5. No abstract available.

PMID:
23645219
37.

Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.

Stromillo ML, Giorgio A, Rossi F, Battaglini M, Hakiki B, Malentacchi G, Santangelo M, Gasperini C, Bartolozzi ML, Portaccio E, Amato MP, De Stefano N.

Neurology. 2013 Jun 4;80(23):2090-4. doi: 10.1212/WNL.0b013e318295d707. Epub 2013 May 1.

PMID:
23635962
38.

Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study.

Amato MP, Razzolini L, Goretti B, Stromillo ML, Rossi F, Giorgio A, Hakiki B, Giannini M, Pastò L, Portaccio E, De Stefano N.

Neurology. 2013 May 7;80(19):1728-33. doi: 10.1212/WNL.0b013e3182918c6f. Epub 2013 Apr 10.

PMID:
23576622
39.

Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.

Pastò L, Portaccio E, Ghezzi A, Hakiki B, Giannini M, Razzolini L, Piscolla E, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, La Mantia L, Mancardi GL, Solaro C, Totaro R, Tola MR, Di Tommaso V, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

BMC Neurol. 2012 Dec 31;12:165. doi: 10.1186/1471-2377-12-165.

40.

Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation.

Carrai V, Donnini I, Mazzanti B, Alterini R, Amato MP, Barilaro A, Bosi A, Massacesi L, Portaccio E, Repice AM, Rotunno G, Saccardi R.

Clin Neurol Neurosurg. 2013 Jul;115(7):1044-8. doi: 10.1016/j.clineuro.2012.10.032. Epub 2012 Dec 5.

PMID:
23218837
41.

Relevance of brain lesion location to cognition in relapsing multiple sclerosis.

Rossi F, Giorgio A, Battaglini M, Stromillo ML, Portaccio E, Goretti B, Federico A, Hakiki B, Amato MP, De Stefano N.

PLoS One. 2012;7(11):e44826. doi: 10.1371/journal.pone.0044826. Epub 2012 Nov 5.

42.

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.

Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Piscolla E, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, La Mantia L, Mancardi G, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP.

BMC Neurol. 2012 Oct 22;12:124. doi: 10.1186/1471-2377-12-124.

43.

Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis--a prospective, non-randomized pilot study.

Portaccio E, Stromillo ML, Goretti B, Hakiki B, Giorgio A, Rossi F, De Leucio A, De Stefano N, Amato MP.

Eur J Neurol. 2013 Jun;20(6):986-90. doi: 10.1111/j.1468-1331.2012.03882.x. Epub 2012 Oct 11.

PMID:
23057658
44.

Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases.

Hakiki B, Portaccio E, Giannini M, Razzolini L, Pastò L, Amato MP.

Mult Scler. 2012 Nov;18(11):1636-9. doi: 10.1177/1352458512454773. Epub 2012 Jul 24.

PMID:
22829326
45.

Immunomodulatory therapies delay disease progression in multiple sclerosis.

Bergamaschi R, Quaglini S, Tavazzi E, Amato MP, Paolicelli D, Zipoli V, Romani A, Tortorella C, Portaccio E, D'Onghia M, Garberi F, Bargiggia V, Trojano M.

Mult Scler. 2016 Nov;22(13):1732-1740. Epub 2012 May 31.

PMID:
22653657
46.

Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.

Iaffaldano P, Viterbo RG, Paolicelli D, Lucchese G, Portaccio E, Goretti B, Direnzo V, D'Onghia M, Zoccolella S, Amato MP, Trojano M.

PLoS One. 2012;7(4):e35843. doi: 10.1371/journal.pone.0035843. Epub 2012 Apr 25.

47.

No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis.

Amato MP, Saia V, Hakiki B, Giannini M, Pastò L, Zecchino S, Lori S, Portaccio E, Marinoni M.

Mult Scler. 2012 Dec;18(12):1791-6. doi: 10.1177/1352458512445943. Epub 2012 Apr 18.

PMID:
22513520
48.

Association of MRI metrics and cognitive impairment in radiologically isolated syndromes.

Amato MP, Hakiki B, Goretti B, Rossi F, Stromillo ML, Giorgio A, Roscio M, Ghezzi A, Guidi L, Bartolozzi ML, Portaccio E, De Stefano N; Italian RIS/MS Study Group.

Neurology. 2012 Jan 31;78(5):309-14. doi: 10.1212/WNL.0b013e31824528c9. Epub 2012 Jan 18.

PMID:
22262744
49.

Management options in multiple sclerosis-associated fatigue.

Amato MP, Portaccio E.

Expert Opin Pharmacother. 2012 Feb;13(2):207-16. doi: 10.1517/14656566.2012.647767. Epub 2012 Jan 6. Review.

PMID:
22220738
50.

Truly benign multiple sclerosis is rare: let's stop fooling ourselves--yes.

Amato MP, Portaccio E.

Mult Scler. 2012 Jan;18(1):13-4. doi: 10.1177/1352458511431732. Epub 2011 Dec 6. No abstract available.

PMID:
22146607

Supplemental Content

Loading ...
Support Center